News about "The United Laboratories International Holdings Lim"

TUL Signs Exclusive License Deal with Novo Nordisk for UBT251

TUL Signs Exclusive License Deal with Novo Nordisk for UBT251

Under the license agreement, Novo Nordisk will obtain exclusive worldwide rights (excluding Chinese mainland, Hong Kong, Macau, and Taiwan) to develop, manufacture, and commercialize UBT251.

The United Laboratories International Holdings Lim | 25/03/2025 | By Aishwarya


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members